Kurs
-0,45%
Likviditet
0,11 MEUR
Kalender
| Est. tid* | ||
| 2026-11-06 | 08:00 | Kvartalsrapport 2026-Q3 |
| 2026-08-14 | 08:00 | Kvartalsrapport 2026-Q2 |
| 2026-05-08 | N/A | Årsstämma |
| 2026-05-06 | 08:00 | Kvartalsrapport 2026-Q1 |
| 2026-02-10 | N/A | Bokslutskommuniké 2025 |
| 2025-11-06 | 08:00 | Kvartalsrapport 2025-Q3 |
| 2025-08-07 | - | Kvartalsrapport 2025-Q2 |
| 2025-05-14 | - | X-dag ordinarie utdelning OPTOMED 0.00 EUR |
| 2025-05-06 | - | Kvartalsrapport 2025-Q1 |
| 2025-02-13 | - | Bokslutskommuniké 2024 |
| 2024-11-07 | - | Kvartalsrapport 2024-Q3 |
| 2024-08-08 | - | Kvartalsrapport 2024-Q2 |
| 2024-05-13 | - | X-dag ordinarie utdelning OPTOMED 0.00 EUR |
| 2024-05-10 | - | Årsstämma |
| 2024-05-07 | - | Kvartalsrapport 2024-Q1 |
| 2024-02-15 | - | Bokslutskommuniké 2023 |
| 2023-11-03 | - | Kvartalsrapport 2023-Q3 |
| 2023-08-04 | - | Kvartalsrapport 2023-Q2 |
| 2023-05-11 | - | X-dag ordinarie utdelning OPTOMED 0.00 EUR |
| 2023-05-10 | - | Årsstämma |
| 2023-05-05 | - | Kvartalsrapport 2023-Q1 |
| 2023-02-17 | - | Bokslutskommuniké 2022 |
| 2022-11-03 | - | Kvartalsrapport 2022-Q3 |
| 2022-09-06 | - | Extra Bolagsstämma 2022 |
| 2022-08-04 | - | Kvartalsrapport 2022-Q2 |
| 2022-05-11 | - | X-dag ordinarie utdelning OPTOMED 0.00 EUR |
| 2022-05-10 | - | Årsstämma |
| 2022-05-05 | - | Kvartalsrapport 2022-Q1 |
| 2022-02-17 | - | Bokslutskommuniké 2021 |
| 2021-11-04 | - | Kvartalsrapport 2021-Q3 |
| 2021-08-05 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-06 | - | Kvartalsrapport 2021-Q1 |
| 2021-04-29 | - | X-dag ordinarie utdelning OPTOMED 0.00 EUR |
| 2021-04-28 | - | Årsstämma |
| 2021-02-18 | - | Bokslutskommuniké 2020 |
| 2020-11-25 | - | Kvartalsrapport 2020-Q3 |
| 2020-08-27 | - | Kvartalsrapport 2020-Q2 |
| 2020-06-12 | - | X-dag ordinarie utdelning OPTOMED 0.00 EUR |
| 2020-06-11 | - | Årsstämma |
| 2020-05-29 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-28 | - | Bokslutskommuniké 2019 |
Beskrivning
| Land | Finland |
|---|---|
| Lista | Small Cap Helsinki |
| Sektor | Hälsovård |
| Industri | Medicinteknik |
Optomed PlcPress Release3 August 2023 at 11.00, Helsinki
Correction: the conference id for Optomed's January-June 2023 half year report telephone conference has changed
The conference id for the Optomed Q2 telephone conference has changed. The new conference id is 179 385 659#.
Optomed will publish its January-June 2023 half year report on 4 August 2023 approximately at 9.00 EEST.
A telephone conference for analysts, investors and media will be arranged on the publishing day at 11.00 EEST/10.00 CET. The event will be held in English. The presentation material will be available at www.optomed.com/investors 10.00 EEST at the latest.
The participants are requested to register for the call in advance by email to sakari.knuutti@optomed.com.
Please see the call-in numbers below:
FI +358 9 8562 6300
FR +33 1 70 99 53 92
SE +46 8 505 218 52
UK +44 20 3321 5273
US +1646838 1719
The conference id is179 385 659#.
Please note that by dialling in to the conference call, the participant agrees that personal information such as name and company name will be collected.
Optomed Plc
Further enquiries
Sakari Knuutti, CFO, Optomed Plc, sakari.knuutti@optomed.com,+358 50562 4077
Optomed in Brief
Optomed is a Finnish medical technology company and one of the leading providers of handheld fundus cameras. Optomed combines handheld screening devices fundus cameras with software and artificial intelligence with the aim to transform the diagnostic process of eye-diseases such as rapidly increasing diabetic retinopathy. In its business Optomed focuses on eye-screening devices and software solutions related R&D in Finland and sales through different channels in over 60 countries.